Outlook Therapeutics Inc (OTLK)
8.71
+0.11
(+1.28%)
USD |
NASDAQ |
May 06, 13:34
Outlook Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 5.854M |
| June 30, 2019 | 0.5838M |
| March 31, 2019 | 0.6411M |
| December 31, 2018 | 1.068M |
| September 30, 2018 | 0.7719M |
| June 30, 2018 | 0.7719M |
| March 31, 2018 | 0.7719M |
| December 31, 2017 | 0.7719M |
| September 30, 2017 | 2.902M |
| June 30, 2017 | 0.3031M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.3031M |
| December 31, 2016 | 0.3031M |
| September 30, 2016 | 0.4949M |
| June 30, 2016 | 0.4949M |
| March 31, 2016 | 0.9949M |
| December 31, 2015 | 0.9949M |
| September 30, 2015 | 0.4949M |
| June 30, 2015 | 1.295M |
| March 31, 2015 | 0.4949M |
| December 31, 2014 | 2.935M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.5838M
Minimum
Jun 2019
5.854M
Maximum
Sep 2019
3.219M
Average
3.219M
Median
Revenue (Quarterly) Benchmarks
| Cutera Inc | 49.54M |
| Actinium Pharmaceuticals Inc | -- |
| GT Biopharma Inc | -- |
| Karyopharm Therapeutics Inc | 33.75M |
| Marinus Pharmaceuticals Inc | 7.19M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.18M |
| Total Expenses (Quarterly) | 10.32M |
| EPS Diluted (Quarterly) | -0.80 |
| Enterprise Value | 211.81M |
| Earnings Yield | -45.92% |
| Normalized Earnings Yield | -486.09 |